Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

GSK holding history

GSK plc in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
71,423
Value
$3.74M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202671,423$3.74M<0.1%−30,263−29.8%ReducedHolders
Q1 2026101,686$5.61M<0.1%+28,362+38.7%AddedHolders
Q4 202573,324$3.60M<0.1%+494+0.7%AddedHolders
Q3 202572,830$3.14M<0.1%+2,657+3.8%AddedHolders
Q2 202570,173$2.69M<0.1%−18,865−21.2%ReducedHolders
Q1 202589,038$3.45M<0.1%+1,191+1.4%AddedHolders
Q4 202487,847$2.97M<0.1%−14,808−14.4%ReducedHolders
Q3 2024102,655$4.20M<0.1%−1,916−1.8%ReducedHolders
Q2 2024104,571$4.02M<0.1%−27,185−20.6%ReducedHolders
Q1 2024131,756$5.65M0.1%+2,433+1.9%AddedHolders
Q4 2023129,323$4.79M<0.1%−73−0.1%ReducedHolders
Q3 2023129,396$4.69M0.1%−3,243−2.4%ReducedHolders
Q2 2023132,639$4.73M<0.1%−2,154−1.6%ReducedHolders
Q1 2023134,793$4.79M0.1%+10,371+8.3%AddedHolders
Q4 2022124,422$4.37M0.1%+5,440+4.6%AddedHolders
Q3 2022118,982$3.50M<0.1%−63,849−34.9%ReducedHolders
Q2 2022182,831$7.96M0.1%+29,500+19.2%AddedHolders
Q1 2022153,331$6.68M0.1%+2,934+2.0%AddedHolders
Q4 2021150,397$6.63M0.1%−1,975−1.3%ReducedHolders
Q3 2021152,372$5.82M0.1%−18,448−10.8%ReducedHolders
Q2 2021170,820$6.80M0.1%−51,449−23.1%ReducedHolders
Q1 2021222,269$7.93M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.